Oncology Corporate Profile
Medifocus, Inc. develops and commercializes minimally invasive treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia. The Company owns two technology platforms with approximately 100 issued and pending US and international patents.
Website: http://www.medifocusinc.com
| Brand / Product | Class | Area of Study | Phase | Partnership |
|---|---|---|---|---|
| APA-1000 | adaptive phased array (APA) | Breast cancer | III |
3/16/2017 01:01 pm
[Accesswire] - COLUMBIA, MD / ACCESSWIRE / March 16, 2017 / Medifocus, Inc. (OTCQB: MDFZF and TSX-V: MFS.V) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products ...
3/14/2017 05:00 pm
12/19/2016 03:00 pm
[Accesswire] - COLUMBIA, MD / ACCESSWIRE / December 19, 2016 / Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products ...
10/3/2016 04:01 pm
[CNW Group] - Medifocus Inc. Announces Appointment of New Chief Executive Officer
10/3/2016 04:01 pm
[PR Newswire] - COLUMBIA, MD, Oct. 3, 2016 /PRNewswire/ - Medifocus, Inc. (OTCQX:MDFZF and TSXV:MFS.V) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and Breast Cancer, today announced the appointment of William Jow, M.D. to the position of Chief Executive Officer, effective October 1, 2016, replacing Augustine Y. Cheung, Ph.D., the founder of the Company. "We thank Dr. Cheung for his service at Medifocus and wish Dr. Cheung the best in the next phase of his career." said Mr. Grant Walsh, Chairman of the Board of Directors.
9/14/2016 09:00 pm
[CNW Group] - Medifocus Inc. Announces Election of Directors and Financial Results for the Quarter Ended June 30 2016
9/14/2016 09:00 pm
[PR Newswire] - COLUMBIA, MD, Sept. 14, 2016 /PRNewswire/ - Medifocus, Inc. (OTCQX:MDFZF and TSXV:MFS.V) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products ...
1/13/2016 01:00 pm
[Marketwired] - Medifocus, Inc. , a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia and Breast Cancer, and heat activated ...
1/11/2016 01:00 pm
[Marketwired] - Medifocus, Inc. a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia and Breast Cancer, and Heat Activated Tumor ...
12/14/2015 03:05 pm
[Marketwired] - Medifocus Inc. announces that it has completed the first tranche of its previously announced private placement. The Company issued 78.5 Units at a price of U.S. $10,000 per Unit for gross proceeds of U.S. ...
12/7/2015 02:05 pm
[Marketwired] - Medifocus, Inc. reported its financial results for the second fiscal quarter ending September 30, 2015.
12/1/2015 01:01 pm
[at noodls] - Medifocus Inc. Obtains Two Newly Allowed Canadian Patents on the Prevention and Safety for the Treatment for Breast Cancer COLUMBIA, Md. and Toronto, ON- December 5, 2014 - Medifocus, Inc. (OTCQX: MDFZF ...
10/29/2015 08:05 am
[at noodls] - Medifocus Inc. Announces Exclusive Agreement With Major Academic Medical Center to License Technology to Develop Heat-Activated and Tumor-Targeted Immunotherapy and Gene Therapy COLUMBIA, Md. and Toronto, ...
10/19/2015 12:03 pm
[Marketwired] - Medifocus, Inc. , a medical systems and devices company that develops and commercializes focused heat thermotherapy systems for the treatment of Benign Prostatic Hyperplasia and Breast Cancer, today announced ...
10/15/2015 08:03 pm
[Marketwired] - Medifocus, Inc. , a medical systems and devices company that develops and commercializes focused heat thermotherapy systems for the treatment of Benign Prostatic Hyperplasia and breast cancer, today announced ...
10/6/2015 12:00 pm
[PR Newswire] - COLUMBIA, Md. and TORONTO, Oct. 6, 2015 /PRNewswire/ -- Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical technologies that utilizes heat-activation to treat conditions ranging from urological problems to breast cancer treatment and extends to gene therapy, today announced that the October 1 presentation from Dr. Augustine Y. Cheung, PhD, President and CEO, is now available for on-demand viewing at VirtualInvestorConferences.com.
10/6/2015 12:00 pm
[CNW Group] - Medifocus, Inc. Presentation Now Available for On-Demand Viewing
10/1/2015 11:01 pm
[at noodls] - Medifocus Inc. Announces Approach of Major Milestone of 100,000 Prolieve(R) Treatments COLUMBIA, Md. and Toronto, ON- September 30, 2015 - Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) (Medifocus or the ...
9/30/2015 03:00 pm
[Marketwired] - Medifocus, Inc. , a biotechnology company with a portfolio of medical technologies that utilizes heat-activation to treat conditions ranging from urological problems to breast cancer treatment and extends ...
9/29/2015 12:05 pm
[PR Newswire] - COLUMBIA, Md. and TORONTO, Sept. 29, 2015 /PRNewswire/ -- Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical technologies that utilizes heat-activation to treat conditions ranging from urological problems to breast cancer treatment and extends to gene therapy, announced today that Dr. Augustine Y. Cheung, PhD, President and CEO), will present live at VirtualInvestorConferences.com on October 1, 2015. On June 16th, 2015, the Company appointed Christopher Kaplan as a member of the its recently formed Strategic Advisory Board (SAB).
9/29/2015 12:05 pm
[CNW Group] - Medifocus, Inc. to Present Live via Webcast at VirtualInvestorConferences.com on October 1, 2015 at 10:45am ET
